Immunogen Inc
IMGN
IMGN was delisted on the 9th of February, 2024.
151 hedge funds and large institutions have $746M invested in Immunogen Inc in 2015 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 48 increasing their positions, 52 reducing their positions, and 12 closing their positions.
100% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 12
53% more call options, than puts
Call options by funds: $4.04M | Put options by funds: $2.64M
8% more funds holding
Funds holding: 140 → 151 (+11)
8% less repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 52
34% less capital invested
Capital invested by funds: $1.13B → $746M (-$387M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$37.5M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
+$17.9M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$13M |
| 4 |
D.E. Shaw & Co
New York
|
+$6.99M |
| 5 |
Renaissance Technologies
New York
|
+$5.75M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$35.3M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$24.9M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$10M |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$5.3M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$3.5M |
IMGN Hedge Fund Activity: Q3 2015 in Review
151 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q3 2015, worth a combined $746M — down 34% from $1.13B a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new IMGN positions and 12 closed out — a net gain of 12 holders — while 48 added to existing stakes and 52 trimmed.
The largest buyer was OrbiMed, adding an estimated $37.5M. The largest seller was Millennium Management, cutting an estimated $35.3M.
- 151 institutional investors held Immunogen Inc (IMGN) as of Q3 2015, up from 140 in Q2 2015.
- Funds reported $746M of Immunogen Inc stock for Q3 2015, down 34% quarter-over-quarter.
- 24 funds opened new Immunogen Inc positions in Q3 2015 and 12 closed out, a net change of +12 holders.
- The largest Immunogen Inc buyer in Q3 2015 was OrbiMed, an estimated $37.5M added.
- The largest Immunogen Inc seller in Q3 2015 was Millennium Management, an estimated $35.3M sold.
Based on aggregated 13F filings for Q3 2015.